A Type 1 diabetes drug developed by London-based GlaxoSmithKline and Cambridge, Massachusetts-based Tolerx, was not successful in the phase III clinical trials.
Racial Disparity in Type 2 Diabetes may be Explained by Potassium Levels
Lower potassium levels in the blood may help explain why African-Americans are twice as likely to be diagnosed with type 2 diabetes as whites, a new study has suggested
Lower potassium levels in the blood may help explain why African-Americans are twice as likely to be diagnosed with type 2 diabetes as whites, a new study has suggested
Source-Medindia
Fatty Liver May Lead To Type 2 Diabetes Risk
In a new study, scientists have found that individuals with fatty liver were five times more likely to develop Type 2 diabetes than those without fatty liver.
In a new study, scientists have found that individuals with fatty liver were five times more likely to develop Type 2 diabetes than those without fatty liver.
Millions With Type 2 Diabetes Go Undiagnosed
A recent report by the World Health Organization reveals a dangerous trend among millions of people in the developed and developing nations of the world- Type 2 diabetes.
A recent report by the World Health Organization reveals a dangerous trend among millions of people in the developed and developing nations of the world- Type 2 diabetes.
Surgery As An Option To Treat Type 2 Diabetes?
Experts are conducting a new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center to test whether surgery is best option for type 2 diabetes.
Experts are conducting a new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center to test whether surgery is best option for type 2 diabetes.
